Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 50090-5107

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 50090-5107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)
This text appears to be a graph or chart showing the percentage of patients achieving different levels of response threshold for Tramadol Hydrochloride Extended-Release Tablets. The graph shows the percentages on the y-axis (ranging from 0 to 60) and the response thresholds on the x-axis (ranging from 10 to 100). There are different dosage levels of the tablets indicated by various symbols. The graph also includes a placebo group. The exact details and interpretation of the graph may not be clear due to the limitations of .*
FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

FDA Label Image

Label Image (Lbl500905107)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.